TLDR:
– Swiss VC firm Redalpine raises $200M fund for early-stage investments
– Fund oversubscribed due to strong returns from previous vintages
Many VC funds have failed to return money to their investors, but Swiss VC firm Redalpine is an exception. Their newly announced $200 million seventh early-stage fund, Redalpine Capital VII (RAC VII), is already well under way to back 15 to 20 European early-stage companies, with nine investments so far. The fund was oversubscribed due to the firm’s consistent top quartile returns, which have averaged 24% per annum over the last 10 years. Redalpine’s focus on European deep tech, university spinouts, and a wide range of sectors has helped them secure fresh funding and navigate market volatility. With a team that includes 50% of investment professionals with a scientific or engineering background, Redalpine is well-positioned to interact with scientific founders and provide operational support. Their upcoming London office aims to tap into the ecosystem emerging from universities in the UK, such as the University of Cambridge spinout, ExpressionEdits, which is developing a computational gene editing platform leveraging AI to improve therapies.
